Recce Pharmaceuticals (ASX:RCE) Achieves Phase II Trial Milestone
Recce Pharmaceuticals (ASX:RCE) successfully dosed all patients in its Phase II trial for R327 topical gel, showing promising preliminary results.
Recce Pharmaceuticals (ASX:RCE) successfully dosed all patients in its Phase II trial for R327 topical gel, showing promising preliminary results.
Stavely Minerals announces exploration advancements at its copper-gold projects in Victoria, focusing on the S41 and Junction prospects.
Carnarvon Energy updates on the Dorado project, postponing key milestones while maintaining a solid financial position.
Centaurus Metals Limited announces the successful production of high-grade 34% nickel concentrate, significantly enhancing the Jaguar Project’s economics.
Centrex Limited (ASX:CXM) unveils an entitlement offer to raise A$10.4 million for operational and infrastructural advancements.
Ava Risk Group Limited (ASX: AVA) reports a strong Q2 FY2025 with significant revenue growth and positive EBITDA.
Liontown Resources (ASX:LTR) reports strong production and financial performance for the December quarter, achieving positive cash flow.
Kali Metals (ASX:KM1) announces an 80% increase in gold anomaly at Marble Bar Gold-Lithium Project, now measuring 9.5km.
88 Energy Limited reports key developments across its exploration projects in the latest quarterly activities report.
Iron Road Ltd (ASX:IRD) reports milestone payments received and project advancements at Cape Hardy.